Navigation Links
Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
Date:8/11/2008

BEIJING, Aug. 11 /Xinhua-PRNewswire/ -- Sinovac Biotech Ltd. (Amex: SVA), a vaccine-focused biotech company in China, announced today that it will hold its 2007 Annual Meeting of Shareholders on Thursday, September 4, 2008 at 9:00 a.m. Beijing Time. The meeting will be held concurrently at No. 39 Shangdi Xi Road, Haidian District, Beijing, PRC and at No. 6 Temple Street, St. John's, Antigua. All shareholders of record as of August 1, 2008 will be eligible to vote and are invited to attend.

Sinovac Biotech Ltd.'s 2007 Annual Report, notice of annual general meeting and proxy statement are available on the investors section of the Company's website http://www.sinovac.com .

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's commercialized vaccines include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A and B), Anflu(R) (influenza) and Panflu(TM) (H5N1). Sinovac is currently developing Universal Pandemic Influenza vaccine and Japanese encephalitis vaccine. Additional information about Sinovac is available on its website, http://www.sinovac.com . To be added to our distribution list, please email: info@sinovac.com.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the business outlook and quotations from management in this press release contain forward-looki
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Sinovac Announces Postponement of Annual General Meeting
2. Sinovac Requests Extension for Annual Shareholders Meeting
3. Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
4. Sinovac Closes $9.75 Million Private Placement
5. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
6. Sinovac Announces Adjournment of Annual General Meeting
7. Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2007 Financial Results
8. Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results
9. Sinovac Biotech Holds Annual General Meeting
10. Sinovac to Present at the Brean Murray, Carret & Co. All-Cap All-China Conference and the Roth China Discovery Tour 2008
11. Sinovac Receives RMB 20 Million Purchase Order for Healive from Chinas Ministry of Health to Vaccinate Earthquake Victims

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,, SEATTLE,Nov.24/PRNewswire/--BlueMarbleEner...licDevelopmentAuthority(OPDA)wererecentlyawarded$2...izationBoard(CERB)inaprivate/publicpartnershiptoco...eryinLincolnCounty,WA. ,, "Thisinvestmentwillsi...ringover70greenjobstoLincolnCounty,"saidBlueMarble...
(Date:11/24/2009)...,, SANDIEGO,Nov.24,2009/PRNewswire-FirstCall/...d todaythatthecompanyisscheduledtopresentatthePip...,2009at11:30a.m.EasternTime(8:30a.m.PacificTime)at...s President andChiefExecutiveOfficer,isscheduledto...developmentanddiscoveryprograms. ,, Aliveaudiow...
(Date:11/24/2009)...,, SEATTLE,Nov.24/PRNewswire-FirstCall/--Cell...twillpresentatthe21stAnnualPiperJaffrayHealthCareC...attheNewYorkPalaceHotel. ,, CTIwillpresentonTue...loor).AliveaudiowebcastofCTI,spresentationwillbeav...eavailableforreplayafterwards. , ,PiperJaffrayHea...
(Date:11/23/2009)...,, INCLINEVILLAGE,Nev.,Nov.23/PRNewswire-Firs...announcedthatNASDAQhasestablishedNovember27,2009as...tostockholdersresultingfromthesecuritizationtransa...idonDecember15,2009toallstockholdersofrecordonther...epershareamountofthedividendat$1.67pershareofcommo...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2
...dings Presented at the American College of Cardiol...c Session -, FREMONT, Calif., April 8, 2008 Verm...ics company, presented data from a,study providing...tein,biomarker panel may aid in the diagnosis of p...sts that such a panel may be useful in alerting,ph...
...O, Calif., April 8, 2008 BioMarin,Pharmaceutical ...ean-Jacques Bienaime, Chief Executive Officer of B...n Tuesday, April 29, at 5:00 p.m. ET (23:00,CET) t... U.S. / Canada Dial-in Number: 866.713.8310 Inte...nt Code: 30774883 Replay Dial-in Number: 888.286....
...RD, Ohio, April 8, 2008 NanoLogix, Inc.,(OTC Pink...ces publication,of 2007 financial data and a direc...ited financials. 2007 expenditures were,reduced by...d Development,was increased by 19%. The informatio.../financials.html , NanoLogix welcomes Bert Pharis...
Other Biology Technology:Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease 2Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease 3BioMarin to Host First Quarter 2008 Financial Results Conference Call and Webcast on Tuesday, April 29 at 5:00 p.m. ET (23:00 CET) 2NanoLogix Inc. Provides Financial Update, Appoints Bert Pharis as New Director 2
(Date:11/23/2009)...pplied mathematicians dissected the morphology of ...ristic long leaf with a saddle-like arc midsection...imple cause of the lily,s fan-like shapeelastic re...l growthwas revealed by using an equally simple te... a postdoctoral student at Harvard,s School of Eng...
(Date:11/23/2009)...ncontrovertible evidence" that the volcanic super-...,000 years ago deforested much of central India, s...port. , The volcano ejected an estimated 800 cub...a crater (now the world,s largest volcanic lake) t... Ash from the event has been found in India, the I...
(Date:11/23/2009)...e microbiologist Louis Tisa has received two grant...e actinorhizal plants, widespread woody plants wit...ed soils. , The United States Department of Agr...ular, cellular and biomedical sciences, $399,000 t...acteria Frankia and Casuarina, an actinorhizal pla...
Breaking Biology News(10 mins):The cause behind the characteristic shape of a long leaf revealed 2Supervolcano eruption -- in Sumatra -- deforested India 73,000 years ago 2UNH prof. receives nearly $500,000 to research environmentally significant plants 2New Therapy Spares Organ in Early Esophageal Cancer 55922 1New Therapy Spares Organ in Early Esophageal Cancer 55922 2Prodrug could help curb skin toxicity related to EGFR inhibiting cancer drugs 55918 1Prodrug could help curb skin toxicity related to EGFR inhibiting cancer drugs 55918 2Trauma 411 3A Prolonged surgery should be avoided in certain cases 55913 1Trauma 411 3A Prolonged surgery should be avoided in certain cases 55913 2
...et weapon of bacteria -- the way they get a footho... secret, according to research published this week... study is the bacterial pathogen Pseudomonas syrin...l speck. The pathogen reared its speckled head in ...ng Yang He describes using P. syringae in the labo...
...ers believe that dynamic regions of the human geno...tions -- are potentially involved in the rapid evo...tics that are genetically determined. , Now, an in...ate student and an associate professor from Arizon...n chimpanzees, which has implications for the unde...
...and the processes of deterioration that go with it...n a controlled manner. Therefore, gaining better u... important in the fight against deterioration dise...rom the Flanders Interuniversity Institute for Bio...ollaboration with researchers from the Dulbecco-Te...
Other Biology News:Chimpanzee study reveals genome variation hotspots 2Scientists identify protein with a crucial role in cell death 2
Goat Anti-Human SART1 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-IkappaB-alpha Monoclonal Antibody, Unconjugated, Clone 112B2 from Cell Signaling Technology
Rhodamine-B-isothiocyanate from Research Organics, Inc.
Anti-Dopamine D2 / D3 Receptor Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: